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doi:10.1016/j.jfma.2011.09.007Background/Purpose: Despite effective vaccine programs, tetanus is occasionally observed in
adults. We reviewed clinical presentation data for adult patients with tetanus in the post-
vaccine era in Taiwan.
Methods: We retrospectively reviewed the medical records of all adult patients (age
>18 years) discharged from Chang-Gung Memorial Hospital at Lin-Ko (CGMHLK) after treatment
for tetanus between January 1996 and July 2005. Data regarding demographic characteristics,
clinical manifestation, treatment, and outcome were collected. To assess the features for
different age groups, patients were divided into those aged 65 years and those aged
<65 years. To identify risk factors for respiratory failure, the patients were classified as those
with and without respiratory failure.
Results: Twenty-three patients with tetanus, 11 (48%) women and 12 (52%) men, were included
in the study. The average age was 57  18 years (range 18e84 years). Eighteen (78%) patients
had a history of acute injury. The average incubation period was 8  5 days. The most common
clinical presentation at onset was trismus (78%). Thirteen (57%) patients developed respiratory
failure and underwent endotracheal intubation. The most common complication was pneu-
monia (30%). All the patients survived and recovered. Age 65 years was significantly associ-
ated with trismus, dysphagia, dysarthria, and pneumonia. Generalized tetanus subtype and
pneumonia were significant risk factors for respiratory failure.
Conclusion: This study revealed several characteristics of adult tetanus cases in the post-
vaccine era in Taiwan. Further serological studies and improved tetanus vaccinations mayof Neurology, Chang-Gung Memorial Hospital at Keelung, 222 Mai-Chin Rd. Keelung 204, Taiwan.
(C.-L. Wu).
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706 W.-C. Weng et al.be needed to ensure better protection, especially for high-risk populations. The exceptionally
good prognosis for our patients confirms that appropriate treatment, including wound care,
early diagnosis, proper medication, and prevention of complications, is essential in managing
this traditional curable disease.
Copyright ª 2011, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Figure 1 Distribution of patients by age group and gender.Tetanus is a toxin-mediated disease caused by Clostridium
tetani, an anaerobic Gram-positive bacillus. Penetrating
injury can result in inoculation of the bacterial spores,
which are normally present in the guts of mammals and in
the soil. The toxin tetanospasmin blocks the release of g-
aminobutyric acid by inhibitory interneurons and spreads
via retrograde axonal transport and trans-synaptic trans-
mission. Tetanospasmin causes tetanus by blocking inhibi-
tory pathways, especially of the motor and autonomic
nervous systems. After the incubation period, the patients
present with tonic contraction of the skeletal muscles,
intermittent painful muscle spasms, and sympathetic
overactivity. The diagnosis is usually clinical and treatment
is mainly supportive.
Tetanus is a preventable disease. Its incidence has been
declining worldwide since the implementation of immuni-
zation programs. However, it continues to be an important
cause of morbidity and mortality, especially in developing
countries. In developed countries, an emerging problem is
the high risk of infection in the elderly. In Taiwan, an
immunization program has been in place since 1954. There
were 1004 cases reported in 1956, when the incidence
reached a peak and then gradually decreased. Since 1981,
fewer than 20 cases have been reported annually. The
incidence was approximately 0.07/100,000 population in
recent years.1 Although rare, cases of adult tetanus
continue to occur. Therefore, we conducted a retrospec-
tive study to investigate the demographic features, clinical
presentations, complications, treatment, and outcome for
adult tetanus cases reported between 1996 and 2005 in the
post-vaccine era in Taiwan.
Materials and method
We conducted a retrospective review of adult patients aged
>18 years discharged from Chang-Gung Memorial Hospital,
Lin-Kou (CGMHLK) after treatment for tetanus between
January 1996 and July 2005. The CGMHLK is a medical
center located in north Taiwan, with more than 3000
inpatient beds. Tetanus was diagnosed on the basis of
clinical findings by experienced neurologists, and the
diagnosis remained unchanged throughout the hospital stay
and subsequent follow-ups. Patients with an uncertain
diagnosis were excluded from the study. Data regarding
demographic features, presence of concomitant diseases,
wound site, incubation period, clinical manifestations,
hospital course, complications, medication administered,
and outcome were collected. The study protocol was
reviewed and approved by the institutional review board of
Chang-Gung Memory Hospital.
Higher tetanus incidence and poor immunity are
observed in older individuals, so the 23 patients weredivided into two groups aged 65 years and <65 years. The
groups were compared to analyze differences in clinical
characteristics. A severe clinical presentation involves
respiratory failure. Therefore, the patients were also
divided into groups with and without respiratory failure.
The clinical features of these two groups were analyzed to
identify possible risk factors for respiratory failure.
The data were analyzed using Statistical Package for the
Social Sciences version 15.0 (SPSS Inc., Chicago, IL, USA).
For univariate comparison, a chi-square test or Fisher’s
exact test was applied for categorical variables and
a ManneWhitney test for continuous variables. A p value
<0.05 was considered significant.Results
Patient characteristics
Twenty-three patients, 11 (48%) women and 12 (52%) men,
were included in the study. The mean age was 57  18 years
( standard deviation). Age data for all patients are pre-
sented in Fig. 1. Among these patients, four (17%) had
a history of diabetes mellitus (DM). Other concomitant
diseases observed were hypertension (13%), heart disease
(9%), chronic obstructive pulmonary disease (4%), chronic
kidney disease (4%), and cancer (4%). Regarding occupa-
tion, there were three (13%) farmers, two housewives (9%),
one carpenter (4%), one cleaner (4%), and one porter (4%).
Fifteen patients did not report their occupation. The
immune status of the patients was not known, except for
one patient who reported that he had not received
a tetanus immunization in the previous 10 years.
As summarized in Table 1, 18 (78%) patients had a history
of acute skin injury; the other five (22%) had no injury
history. Among these 18 patients, nine (50%) had wounds on
the lower limbs, eight (44%) on the upper limbs, three (17%)
on the head, and one (6%) on the neck. Three of these
Table 1 Clinical presentations at onset.
Clinical presentation at onset Number of
patients, n (%)
Trismus 18 (78)
Dysphagia 12 (52)
Muscle spasm 9 (39)
Neck stiffness 7 (30)
Dysarthria 5 (22)
Muscle pain 2 (9)
Dyspnea 2 (9)
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enced a fall and one was involved in a fight. One patient
had undergone excision of nasal polyps 1 day prior to the
onset of symptoms, while another had no history of acute
injury but was a drug abuser.
Hospital course and complications
The average incubation period was 8  5 days (range 0e60
days). The clinical presentations at onset are summarized
in Table 1. Trismus was the most common initial presenta-
tion, and 19 (89%) of the 23 patients developed generalized
tetanus. The clinical types included local and cephalic
tetanus, each of which was observed in two (9%) patients.
Thirteen (57%) patients developed respiratory failure, with
a mean ventilator dependency duration of 16  10 days
(range 2e37 days). Fifteen patients were admitted to the
intensive care unit (ICU). The average ICU stay was 17  11
days. The average hospitalization duration was 25  15 days
(range 3e58 days). Common complications included pneu-
monia (30%), rhabdomyolysis (13%), upper gastrointestinal
bleeding (9%), acute myocardial infarction (9%), acute renal
failure (4%), secondary wound infection (4%), and transient
cardiac arrest (4%).
Treatment and outcome
Antibiotic treatment was administered to all patients: 19
(83%) were treated with parenteral penicillin and four (17%)
with metronidazole. Eighteen (78%) were treated with
antitoxin. Eleven (48%) patients received injections of
tetanus vaccine during hospitalization. Four (17%) patients
underwent wound debridement. Twenty (87%) patients
were treated with intravenous benzodiazepine to control
muscle spasm. Other antispasmodic agents used were
a non-depolarizing muscle relaxant (four patients) and
baclofen (four patients). All the patients recovered and
were discharged without sequelae.
Statistical analysis
Table 2 compares the clinical features for the patient age
groups 65 years and <65 years. Differences between the
groups in trismus presentation at onset, dysphagia/dysar-
thria, and pneumonia complications were significant.
Trismus (p Z 0.046) and dysphagia/dysarthria [p Z 0.036,
odds ratio (OR) Z 9.000, 95% confidence interval(CI) Z 1.285e63.025] were more common in patients
aged  65 years, and these patients were more susceptible
to pneumonia (p Z 0.019, OR Z 18.00, 95% CI Z 1.632e
198.508).
Table 3 shows a comparison between patients with and
without endotracheal intubation. The two groups differed
significantly in tetanus subtype (generalized or focal type)
and complications (with or without pneumonia). The
patients with generalized tetanus (p Z 0.024) or with
pneumonia (p Z 0.007) were more likely to develop
respiratory failure. They stayed in the ICU (p < 0.001) and
hospital (p Z 0.014) for a significantly longer duration.Discussion
Our data reveal some typical characteristics of tetanus
cases. A higher incidence was observed in older persons.
Individuals greater than 40 years of age comprised 82%
(19/23) of the patients. Trismus and dysphagia were the
two most common initial presentations. Most patients
subsequently developed generalized tetanus (82%). Acute
respiratory failure (57%) and pneumonia (30%) were the
most common complications during hospitalization.
Farming and gardening work are high-risk activities. Wound
locations, incubation period, initial presentations, and
complications were similar to those in previous reports for
Taiwan.2,3
Recent studies in developed countries have revealed
that the high incidence of tetanus in elderly diabetics and
intravenous drug abusers is a major concern.4e6 According
to a survey conducted in the USA between 1998 and 2000,
diabetic patients constituted 12% of the 130 reported cases
of tetanus, and intravenous drug abusers accounted for
15%.4 In our study, four patients (17%) had a history of DM.
The average age of these four patients was 62.8 years,
which is greater than the mean patient age in the study
(57.4 years). With regard to intravenous drug abuse, one
patient had a history of amphetamine abuse. This patient
did not have a history of acute wound, but it was not known
whether he had used unsterilized syringes or needles to
inject other drugs.
Several serological investigations to evaluate immunity
to tetanus in developed countries revealed that most
people, especially the elderly, do not have adequate
immunity to tetanus.7e9 Wu et al reported that tetanus
antitoxin levels decrease with age in Taiwan. Individuals
aged >60 years all had protective antitoxin in their serum,
but might need a booster to increase the level.10 An
immunization program (diphtheria, tetanus, and pertussis
vaccine) was launched in 1954 in Taiwan and has been
popular since 1959. The vaccine is administered to all
infants at 2, 4, and 6 months of age. Booster doses are given
at 18 months and in the first year of elementary school. It is
likely that individuals born before 1954 have never received
any active immunization. A similar situation exists in
developing countries where immunization programs are not
well established.11,12 In our study, a detailed immunization
history was not known for most patients. Only one patient
reported that he had not received tetanus immunization in
the previous 10 years. These findings indicate that inade-
quate immune protection might be a major reason for
Table 2 Comparison of age groups 65 and <65 years.
Number, n (%) p OR 95% CI
65 y <65 y
(n Z 10) (n Z 13)
Male 5 7 1.000 0.9 0.2e4.5
Subtype
Generalized 7 (70) 12 (92) 0.281 0.2 0.0e2.2
Cephalic 2 (20) 0 0.178 d d
Local 1 (10) 1 (8) 1.000 1.3 0.1e24.3
Location of wound
Limbs 6 (60) 7 (54) 1.000 1.3 0.2e6.8
Head or neck 2 (2) 2 (15) 1.000 1.4 0.2e11.9
Concomitant DM 2 (20) 2 (15) 1.000 1.4 0.2-11.9
Presentation at onset
Trismus 10 (100) 8 (62) 0.046* d d
Dysphagia/dysarthria 8 (80) 4 (31) 0.036* 9.0 1.3-63.0
Muscle spasm 3 (30) 8 (62) 0.214 0.3 0.0-1.5
Dyspnea 1 (10) 1 (8) 0.846 1.3 0.1e24.4
Treatment
Antitoxin 11 (85) 7 (70) 0.681 0.4 0.1e3.2
Antibiotics 10 (100) 12 (92.3) 1.000 d d
Complications
Pneumonia 6 (60) 1 (8) 0.019* 18.0 1.6e198.5
Rhabdomyolysis 1 (10) 2 (15) 1.000 0.6 0.0e7.9
UGI bleeding 2 (20) 0 (0) 0.178 d d
AMI 1 (10) 1 (8) 1.000 1.3 0.1e24.3
ARF 1 (10) 0 (0) 0.435 d d
Secondary wound infection 0 (0) 1 (8) 1.000 d d
Ventilator use (d) 11.6  11.2 6.9  10.7 0.348
ICU stay (d) 13.2  12.8 5.9  5.9 0.212
Hospital stay (d) 27.5  15.8 20.1  15.0 0.192
AFRZ acute renal failure; AMIZ acute myocardial infarction; CIZ confidence interval; DMZ diabetes mellitus; ICUZ intensive care
unit; OR Z odds ratio; UGI Z upper gastrointestinal.
*p < 0.05.
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should be considered, especially for populations at high risk
of open wound infection, such as elderly patients with DM
or intravenous drug abusers, as suggested in previous
reports.4,7 Our study also suggests that this should apply to
workers in higher-risk occupations, such as farmers.
Owing to the higher incidence of tetanus among the
elderly and their poor immunity to this disease, early
diagnosis and treatment are important for this group of
patients. Our study reveals that elderly patients may
present with typical symptoms, such as trismus and
dysphagia, more frequently than younger patients.
Although the initial differential diagnosis might be
confusing, tetanus should always be considered in elderly
patients presenting with acute onset of trismus and
dysphagia. Survival depends on rapid treatment with anti-
toxin, high-dose sedatives, muscle relaxants, and adequate
supportive care. Specific therapy includes intramuscular
administration of tetanus immunoglobulin to neutralizecirculating toxin before it binds to neuronal cell
membranes.13 Early prevention of aspiration and adminis-
tration of antibiotics for pneumonia might reduce the
incidence of complications and the cost of treatment.
Mortality usually results from respiratory failure,
cardiovascular collapse, or associated autonomic insta-
bility.3,14 Our results revealed that respiratory failure was
significantly associated with generalized tetanus and
pneumonia. Respiratory failure also results in prolonged ICU
stays. Early endotracheal intubation and even tracheos-
tomy were required in high-risk patients to reduce
morbidity and mortality. Early tracheostomy may shorten
the ICU stay. According to previous studies in other coun-
tries, the mortality rate for tetanus varies from 11% to
70%.4,15e17 A previous study conducted in Taiwan revealed
a mortality rate of 28.6% between 1980 and 1990.3 It is
surprising that there were no fatal cases in our series. The
advanced supportive care provided for our patients might
have contributed to this exceptionally good outcome.
Table 3 Comparison of groups with and without intubation.
Number, n (%) p OR 95% CI
Intubation No intubation
(n Z 13) (n Z 10)
Male 7 (54) 5 (50) 1.000 1.2 0.2e6.1
Born after 1955 1 (8) 3 (30) 0.281 0.2 0.0e2.2
Subtype
Generalized 13 (100) 6 (60) 0.024* d d
Cephalic 0 (0) 2 (20) 0.178 d d
Local 0 (0) 2 (20) 0.178 d d
Location of wound
Limbs 9 (69) 4 (40) 0.222 3.4 0.6e19.0
Head or neck 2 (15) 2 (20) 1.000 0.7 0.1e6.3
Concomitant DM 3 (23) 1 (10) 0.604 2.7 0.1e21.1
Presentation at onset
Trismus 11 (85) 7 (70) 0.618 2.4 0.3e17.9
Dysphagia/dysarthria 7 (54) 5 (50) 1.000 1.2 0.2e6.1
Muscle spasm 7 (54) 4 (40) 0.680 1.8 0.3e9.3
Dyspnea 1 (8) 1 (10) 1.000 0.8 0.0e13.7
Treatment
Antitoxin 9 (69) 9 (90) 0.339 0.3 0.0e2.7
Antibiotics 12 (92) 10 (100) 1.000 d d
Complications
Pneumonia 7 (54) 0 (0) 0.007* d d
Rhabdomyolysis 2 (15) 1 (10) 1.000 1.6 0.1e21.1
UGI bleeding 2 (15) 0 (0) 0.486 d d
AMI 2 (15) 0 (0) 0.486 d d
ARF 1 (8) 0 (0) 1.000 d d
Secondary wound infection 1 (8) 0 (0) 1.000 d d
Age (y) 62.1  14.3 51.4  21.7 0.182
ICU stay (d) 15.0  9.5 1.4  3.0 <0.001*
Hospital stay (d) 28.7  13.0 16.3  16.2 0.014*
AFRZ acute renal failure; AMIZ acute myocardial infarction; CIZ confidence interval; DMZ diabetes mellitus; ICUZ intensive care
unit; OR Z odds ratio; UGI Z upper gastrointestinal.
*p < 0.05.
Clinical characteristics of adult tetanus 709In summary, this study revealed several characteristics
of adult tetanus cases in the post-vaccine era in Taiwan.
Although a public immunization program has been in place
for decades, tetanus still remains a major threat. Further
serological investigations and improved vaccination may be
needed for better protection, especially for high-risk pop-
ulations. The exceptionally good prognosis for our patients
confirms that appropriate treatment, including wound
care, early diagnosis, proper medication, and prevention of
complications, is essential in managing this traditional
curable disease.
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